Sir,

Hearing loss occurs in 155 out of every 100,000 births[@ref1], and in India it was reported as 291 per 100,000, according to the National Sample Survey, 2002[@ref2]. Non-syndromic hearing loss accounts for 70 per cent of all types of hereditary hearing loss. It can be autosomal recessive (80-85%), autosomal dominant (10-15%), X linked (1%) or mitochondrial (\<1%). More than 130 loci and about 95 genes have been identified in non-syndromic hearing loss. Mutations in the *GJB2* (DFNB1) gene are major contributors of pre-lingual hearing loss in various populations including India[@ref3][@ref4]. This locus was first mapped to chromosome 13q11 by linkage analysis in two large consanguineous Tunisian families with pre-lingual profound hearing loss[@ref5]. *GJB2* \[connexin 26 (Cx26)\] gene has two exons, of which only exon 2 (681 bp) is coding. Product of this gene, Cx26, forms a gap junction protein with four transmembrane domains[@ref6]. GJB6 (Cx30), another gene of the connexin family, is also involved in the manifestation of non-syndromic hearing loss. Though many mutations of *GJB2* have been reported in different studies, p. Trp24Ter mutation is known to be the most common cause in India[@ref3][@ref7][@ref8]. Most studies reported a frequency of Cx26 mutations in Indian patients with non-syndromic hearing loss in a small sample. In this study, we report the spectrum of *GJB2* variants as well as a novel variant in a large Indian cohort of 316 families with non-syndromic hearing loss.

These 316 families were enrolled between 2008 and 2015. Of these 70 families were enrolled from various States of India, including Gujarat (22), Delhi (22), Uttar Pradesh (UP, 21) and Madhya Pradesh (MP, 5) through the visit to various hearing impaired schools of the States. Of these 70 families, 28 were consanguineous and 42 non-consanguineous and had two or more hearing impaired children and at least one normal child. The remaining 246 families were referred to the Genetic Clinic, department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India, for mutation analysis of *GJB2* gene. In these 246 families, 37 families were consanguineous and some families had two or more hearing impaired children. The age group ranged from one to 18 years. In a total of 316 families, 537 affected individuals (292 males, 245 females) were screened. No formal sample size calculation was done for this study. *Post hoc* sample size was calculated (*<http://clincalc.com/stats/power.aspx>*) based on the frequency of *GJB2* mutations (10%) in north India[@ref3] with allowable precision at three per cent. This gave a number of 400 individuals. Only cases of non-syndromic hearing loss were selected for the study. Families with recognizable syndromic/environmental causes of hearing loss were excluded. The study was approved by the institutional ethics committee and written consent was obtained from parents/ guardians of all participants even if the families were identified through schools. Permission to visit schools was taken from the concerned ministries.

Peripheral blood sample (2 ml) was taken from all the available affected members, and DNA was extracted by salting out method[@ref9]. Coding exon 2 of *GJB2* gene was amplified at annealing temperature (60°C) by primer set Cx26-2F and Cx26-2R. Polymerase chain reaction products were purified using enzyme (ExoI and SAP) to remove unincorporated deoxynucleotide triphosphates and primers. Bidirectional DNA sequencing of coding exon 2 was performed by four different primers Cx26-2F, Cx26-2R, Cx26-2FI and Cx26-2RI ([Table I](#T1){ref-type="table"}), to cover complete coding and splice site. Primers were designed by Primer3 software (*<http://primer3.ut.ee/>*). Sequence analysis was done with the help of Chromas Pro software (*<http://technelysium.com.au/wp/chromaspro>*), and sequences were aligned by MEGA (*<https://www.megasoftware.net>*) to a reference sequence (ENST00000382848) of *GJB2* gene to identify sequence variants.

###### 

Primers sequence of connexin 26 (*GJB2*) gene
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A total of 17 different variants ([Table II](#T2){ref-type="table"}) were identified in the coding exon 2 of *GJB2* gene. Of these variants, 16 variants (c.35delG, c.71G\>A, c.148G\>A, c.223C\>T, c.231G\>A, c.238C\>T, c.283G\>A, c.313_326del14, c.340G\>A, c.341A\>G, c.370C\>T, c.407dupA, c.439G\>A, c.79G\>A, c.380G\>A and c.457G\>A) are reported variants and c.616A\>C is novel in nature. Of the 17 variants identified, 14 variants (13 reported mutations and one novel variant) were pathogenic variants and three variants were reported as polymorphisms.

###### 

List of variations detected in 316 families
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In the present study, a total of 27 families (20 homozygous and 7 compounds heterozygous) were found positive (8.5%) for Cx26 mutation. One novel variation c.616A\>C (p. Asn206His) was also detected ([Figure](#F1){ref-type="fig"}). The novel transversion c.616A\>C was found in compound heterozygous state with c.71G\>A (p. Trp24Ter) in a singleton non-consanguineous family. This change was predicted to be 'probably damaging' by PolyPhen2 (*<http://genetics.bwh.harvard.edu/pph2>*) and 'damaging' by SIFT (*<http://sift.jcvi.org>*) tools. According to amino acid conservation analysis of GJB2, it appears to be conserved across 52 homologous sequences (UniProtKB/Swiss-Prot, *<https://www.uniprot.org>*) and hence may be presumed to be pathogenic. In the study, p. Trp24Ter mutation was found to be the most common mutation and present in both homozygous and heterozygous state with an allele frequency of six per cent followed by p. Trp77Ter at allele frequency of two per cent. Two reported polymorphisms p. Arg127His (allele frequency 4.2%) and p. Val153Ile (allele frequency 2.85%) were also found in high frequency. Frequency of other reported mutations was very low ([Table II](#T2){ref-type="table"}).
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Frequency of *GJB2* mutations among hearing impaired individuals in India is much lower than European and North American population. The frequency also differs in south and north India[@ref3]. This could be due to the prevalence of assortative mating in European and North American populations[@ref8]. In Pakistan, frequency of Cx26 mutations was reported to be low in one study although consanguinity is twice as high as in India[@ref10]. p. Trp24Ter mutation has been reported to be the most common cause for non-syndromic recessive hearing loss in India, followed by p. Trp77Ter, c.35delG and p. Gln124Ter[@ref3]. p. Trp24Ter was detected as the founder mutation in India with a frequency of 33.9 per cent in a study done in Kerala[@ref11]. Frequency of p. Trp24Ter was six per cent in our study predominately in north Indians. Apart from p. Trp24Ter and p. Trp77Ter, we found a truncating mutation p. Tyr136Ter which is due to duplication of adenine at nucleotide number 407. This mutation has also been reported in Indian population[@ref4]. No regional variation of mutation spectrum of *GJB2* gene was found in the study.

We also screened reported 342 kb deletion[@ref12] for *GJB6* gene mutations in 70 families enrolled from UP, MP, Gujarat and Delhi through deaf schools and also sequenced the coding region in them but did not find any point mutation or the 342 kb deletion. Our results were concordant with earlier reported studies[@ref13][@ref14].

In conclusion, this study showed the spectrum of the *GJB2* (Cx26) gene variants in children with non-syndromic hearing loss from northern (Delhi, UP) and western (Gujarat) regions of India. p.Trp24Ter was found to be the most common mutation noted in the *GJB2* (Cx26) gene in patients with non-syndromic hereditary hearing loss. In addition, one novel change in compound heterozygous form was also found.
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